Income Statement
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
LIXT
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY | Dec 31, 2013 2013 FY | Dec 31, 2012 2012 FY | Dec 31, 2011 2011 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue
|
- | - | - | - | - | - | - | - | - | - | - | - | 0.00 | 0.00 | 0.00 |
|
Cost of Revenue
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Gross Profit
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Operating Expenses
|
5.11 | 3.57 | 5.09 | 6.31 | 6.72 | 3.27 | 2.49 | 2.14 | 1.81 | 2.13 | 2.85 | 2.40 | 1.37 | 2.11 | 1.87 |
|
Research & Development
|
0.25 | 0.73 | 0.90 | 1.35 | 1.74 | 1.22 | 0.82 | 0.04 | 0.47 | 1.30 | 2.09 | 1.12 | 0.88 | 1.01 | 1.33 |
|
Selling, General & Administrative
|
4.85 | 2.85 | 1.72 | 2.55 | 2.93 | 2.04 | 1.67 | 2.10 | 1.34 | 0.83 | 0.75 | 1.29 | 0.49 | 1.09 | 0.53 |
|
Other Operating Expenses
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Operating Income
|
-5.11 | -3.57 | -5.09 | -6.31 | -6.72 | -3.27 | -2.49 | -2.14 | -1.81 | -2.13 | -2.85 | -2.40 | -1.37 | -2.11 | -1.87 |
|
Non-Operating Income
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Interest Income
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Interest Expense
|
0.01 | 0.02 | 0.02 | 0.01 | 0.01 | 0.00 | - | - | - | - | - | - | 0.00 | 0.00 | 0.00 |
|
Other Non-Op Income / Expense
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Income Before Tax
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Income Tax Expense
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Non-Controlling Interest
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Net Income
|
-6.08 | -3.59 | -5.09 | -6.31 | -6.73 | -3.26 | 2.44 | 2.13 | 1.81 | 2.39 | 3.14 | -2.77 | 0.00 | 0.00 | 0.00 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY | Dec 31, 2013 2013 FY | Dec 31, 2012 2012 FY | Dec 31, 2011 2011 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
EBITDA
|
-5.11 | -3.57 | -5.09 | -6.31 | -6.72 | -3.27 | -2.49 | -2.14 | -1.81 | -2.13 | -2.85 | -2.40 | -1.37 | -2.11 | -1.87 |
|
Earnings Per Share (Basic)
|
- | -1.59 | -2.66 | -0.40 | - | - | - | - | - | - | - | - | - | - | - |
|
Diluted EPS
|
-1.26 | -1.59 | -2.66 | - | - | - | - | - | - | - | - | - | - | - | - |
|
Weighted Average Shares
|
- | 2.25 | 1.92 | 15.82 | - | - | - | - | - | - | - | - | - | - | - |
|
Diluted Weighted Avg Shares
|
4.84 | 2.25 | 1.92 | - | - | - | - | - | - | - | - | - | - | - | - |
|
Comprehensive Income
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |